XML 22 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Statements of Stockholder's Equity (Deficit) (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Jul. 31, 2020 $ 88,560 $ 28,110,689 $ (28,850,728) $ (651,479)
Beginning balance, shares at Jul. 31, 2020 88,559,978      
Conversion of convertible note payable $ 214 106,786 107,000
Conversion of convertible note payable, shares 214,000      
Stock-based compensation 130,301 130,301
Warrants issued in connection with debt financings 128,333 128,333
Common stock issued in debt financing $ 420 196,980 197,400
Common stock issued in debt financing, shares 420,000      
Common stock issued in equity financing $ 1,396 248,604 250,000
Common stock issued in equity financing, shares 1,396,224      
Stock forfeited $ (20) (20)
Stock forfeited, shares (20,000)      
Net loss (711,514) (711,514)
Ending balance, value at Oct. 31, 2020 $ 90,570 28,921,693 (29,562,242) (549,979)
Ending balance, shares at Oct. 31, 2020 90,570,202      
Beginning balance, value at Jul. 31, 2020 $ 88,560 28,110,689 (28,850,728) (651,479)
Beginning balance, shares at Jul. 31, 2020 88,559,978      
Net loss       (13,982,504)
Ending balance, value at Apr. 30, 2021 $ 101,539 41,784,782 (42,833,232) (946,911)
Ending balance, shares at Apr. 30, 2021 101,539,105      
Beginning balance, value at Oct. 31, 2020 $ 90,570 28,921,693 (29,562,242) (549,979)
Beginning balance, shares at Oct. 31, 2020 90,570,202      
Common stock issued for services $ 540 69,460 70,000
Common stock issued for services, shares 540,000      
Stock-based compensation 111,728 111,728
Common stock issued to LGH in connection with debt financing $ 300 83,700 84,000
Common stock issued to LGH in connection with debt financing, shares 300,000      
Beneficial conversion feature of LGH financing 19,780 19,780
Warrants issued in connection with debt financings 82,720 82,720
Common stock issued in equity financing $ 200 34,880 35,080
Common stock issued in equity financing, shares 200,000      
Net loss (869,300) (869,300)
Ending balance, value at Jan. 31, 2021 $ 91,610 29,323,961 (30,431,542) (1,015,971)
Ending balance, shares at Jan. 31, 2021 91,610,202      
Common stock issued for services $ 100 123,150 123,250
Common stock issued for services, shares 100,000      
Stock-based compensation 887,437 887,437
Common stock issued in asset purchase agreement 6,000 8,254,000 8,260,000
Common stock issued in connection with LPC share purchase 1,351 1,185,044 1,186,395
Warrants issued in connection with debt financings 423,003 423,003
Common stock issued in equity financing $ 1,486 1,213,014 1,214,500
Common stock issued in equity financing, shares 1,485,834      
Net loss   (12,401,690) (12,401,690)
Common stock issued in asset purchase agreement, shares 6,000,000      
Conversion of convertible note debt financing $ 298 245,802 246,100
Conversion of convertible note debt financing, shares 298,165      
Conversion of convertible note debt financing in connection with LGH $ 594 88,506 89,100
Conversion of convertible note debt financing in connection with LGH, shares 594,000      
Common stock issued in connection with LPC share purchase, shares 1,350,904      
Common stock issued in connection with LGH financing $ 100 40,865 40,965
Common stock issued in connection with LGH financing, shares 100,000      
Ending balance, value at Apr. 30, 2021 $ 101,539 41,784,782 (42,833,232) (946,911)
Ending balance, shares at Apr. 30, 2021 101,539,105      
Beginning balance, value at Jul. 31, 2021 $ 87,191 42,879,278 (45,733,823) (2,767,354)
Beginning balance, shares at Jul. 31, 2021 87,191,168      
Stock-based compensation 533,105 533,105
Common stock issued in debt financing $ 200 17,518 17,718
Common stock issued in debt financing, shares 200,000      
Common stock issued in equity financing $ 3,974 863,061 867,035
Common stock issued in equity financing, shares 3,974,482      
Stock forfeited $ (350) 350
Stock forfeited, shares (350,000)      
Net loss (1,646,274) (1,646,274)
Ending balance, value at Oct. 31, 2021 $ 91,016 44,293,312 (47,380,097) (2,995,769)
Ending balance, shares at Oct. 31, 2021 91,015,650      
Beginning balance, value at Jul. 31, 2021 $ 87,191 42,879,278 (45,733,823) (2,767,354)
Beginning balance, shares at Jul. 31, 2021 87,191,168      
Net loss       (6,438,258)
Ending balance, value at Apr. 30, 2022 $ 82,878 48,009,467 (52,172,081) (4,079,736)
Ending balance, shares at Apr. 30, 2022 82,876,872      
Beginning balance, value at Oct. 31, 2021 $ 91,016 44,293,312 (47,380,097) (2,995,769)
Beginning balance, shares at Oct. 31, 2021 91,015,650      
Stock-based compensation 511,310 511,310
Stock forfeited $ (8,309) 8,309
Stock forfeited, shares (8,309,578)      
Net loss (1,692,713) (1,692,713)
Ending balance, value at Jan. 31, 2022 $ 82,707 44,812,931 (49,072,810) (4,177,172)
Ending balance, shares at Jan. 31, 2022 82,706,072      
Stock-based compensation 430,726 430,726
Common stock issue in connection with Prevacus milestone $ 1,000 (1,000)  
Common stock issue in connection with Prevacus milestone, shares 1,000,000      
Common stock issued for consulting services $ 3,000 1,607,000 1,610,000
Common stock issued for consulting services, shares 3,000,000      
Vesting of RSUs $ 500 (500)
Vesting of RSUs, shares 500,000      
Common stock issued in debt financing $ 100 50,900 51,000
Common stock issued in debt financing, shares 100,000      
Common stock issued in equity financing $ 3,071 1,101,910 1,104,981
Common stock issued in equity financing, shares 3,070,800      
Stock forfeited $ (7,500) 7,500
Stock forfeited, shares (7,500,000)      
Net loss (3,099,271) (3,099,271)
Ending balance, value at Apr. 30, 2022 $ 82,878 $ 48,009,467 $ (52,172,081) $ (4,079,736)
Ending balance, shares at Apr. 30, 2022 82,876,872